A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01283373
Recruitment Status : Completed
First Posted : January 26, 2011
Last Update Posted : October 4, 2016
Information provided by (Responsible Party):
Genentech, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2016
  Study Completion Date : January 2016